BISPYLLER 140/125/125 MG (120 H.G. CAP)
Bispyller is a combination medication containing bismuth subcitrate potassium, metronidazole, and tetracycline hydrochloride. It is used as part of a combination treatment regimen for the eradication of Helicobacter pylori (H. pylori), a bacterium associated with stomach inflammation and peptic ulcer disease.
The three active ingredients work together through complementary mechanisms to help eliminate H. pylori infection. Treatment is prescribed alongside an acid-reducing medication, such as omeprazole, according to the physician’s instructions. Successful eradication of H. pylori can help reduce the risk of ulcer recurrence in appropriate patients.
Active Ingredients (per capsule):
Bismuth Subcitrate Potassium: 140 mg
Metronidazole: 125 mg
Tetracycline Hydrochloride: 125 mg
Key Uses and Benefits:
Used in combination therapy to help eradicate H. pylori infection.
Helps treat H. pylori-associated peptic ulcer disease as part of an appropriate treatment regimen.
Combines two antimicrobial agents with bismuth in one treatment.
Helps reduce the risk of ulcer recurrence when H. pylori is successfully eradicated.
Directions for Use:
Use strictly as prescribed by a physician. The dosage, treatment duration, and accompanying acid-reducing medication should follow the prescribed regimen. Swallow capsules with sufficient water and complete the full course as directed.
Warnings and Precautions:
Not suitable for use during pregnancy.
Inform your doctor about kidney problems, medication allergies, and all other medicines you take.
Avoid alcohol during treatment and for at least three days after completing it.
Tetracycline may increase sensitivity to sunlight; take appropriate sun-protection measures.
This medication may interact with other medicines and minerals, so consult your pharmacist about the timing of other treatments.
Do not use without medical supervision.
Dosage Form: Hard gelatin capsules
Pack Size: 120 capsules
